Prophylactic antibiotic therapy in chronic obstructive pulmonary disease

Area of Science:

• Pulmonary Medicine
• Infectious Diseases
• Clinical Pharmacology

Background:

• Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent respiratory symptoms and frequent exacerbations.
• Exacerbations significantly impact patient morbidity, mortality, and healthcare costs.
• Prophylactic antibiotic strategies are explored to mitigate COPD exacerbations and improve quality of life.

Purpose of the Study:

• To evaluate the efficacy of prophylactic antibiotic treatment in reducing exacerbations in patients with COPD.
• To assess the impact of prophylactic antibiotics on health-related quality of life (HRQOL) in COPD patients.

Main Methods:

• Systematic review and meta-analysis of randomized controlled trials.
• Inclusion of studies comparing continuous or pulsed macrolide antibiotic prophylaxis versus placebo.
• Assessment of primary outcomes including COPD exacerbation rates and secondary outcomes including HRQOL.

Main Results:

• Continuous macrolide antibiotic prophylaxis was associated with a clinically significant reduction in COPD exacerbations.
• Pulsed macrolide antibiotic prophylaxis did not demonstrate a significant reduction in exacerbations.
• Both continuous and pulsed macrolide regimens showed improvements in HRQOL, but these changes did not reach clinical significance.

Conclusions:

• Continuous prophylactic macrolide antibiotic use is an effective strategy for reducing exacerbations in patients with COPD.
• While HRQOL may improve, the clinical significance of this improvement with prophylactic antibiotics warrants further investigation.
• Current evidence supports continuous macrolide use for exacerbation prevention in select COPD patients.